SHENZHEN HEPALINK PHARMACEUTICAL revenue breakdown overview

SHENZHEN HEPALINK PHARMACEUTICAL revenue for the last year amounted to 5.63 B HKD, the most of which — 3.24 B HKD — came from its highest performing source at the moment, Preparation, the year earlier bringing 3.29 B HKD. The greatest contribution to the revenue figure was made by Europe — last year it brought SHENZHEN HEPALINK PHARMACEUTICAL 2.57 B HKD, and the year before that — 2.89 B HKD.